Spark Investment Management LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$276,000
-48.8%
3,200
-83.0%
0.23%
-20.3%
Q1 2020$539,000
-89.4%
18,800
-32.6%
0.29%
-19.2%
Q2 2019$5,108,000
+248.7%
27,900
+82.4%
0.35%
+250.5%
Q4 2018$1,465,000
+48.3%
15,300
+118.6%
0.10%
+77.2%
Q3 2018$988,000
-77.3%
7,000
-90.0%
0.06%
-75.5%
Q3 2017$4,354,000
-21.8%
69,9000.0%0.23%
-32.1%
Q2 2017$5,566,000
+36.2%
69,900
+21.6%
0.34%
+32.9%
Q1 2017$4,086,000
+1031.9%
57,500
+379.2%
0.26%
+658.8%
Q2 2016$361,000
-82.8%
12,000
-81.7%
0.03%
-84.0%
Q1 2016$2,099,000
+443.8%
65,500
+750.6%
0.21%
+292.6%
Q1 2015$386,000
+57.6%
7,700
+14.9%
0.05%
+31.7%
Q4 2014$245,0006,7000.04%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders